meclizine has been researched along with Idiopathic Parkinson Disease in 1 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Meclizine is a well-tolerated drug routinely used as an anti-histamine agent in the management of disequilibrium." | 5.43 | Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. ( Chau, KY; Hong, CT; Schapira, AH, 2016) |
| "Meclizine is a well-tolerated drug routinely used as an anti-histamine agent in the management of disequilibrium." | 1.43 | Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. ( Chau, KY; Hong, CT; Schapira, AH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CT | 1 |
| Chau, KY | 1 |
| Schapira, AH | 1 |
1 other study available for meclizine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models.
Topics: Animals; Apoptosis; Cell Line; Fructosediphosphates; Gene Expression Regulation; Glycolysis; Humans; | 2016 |